​

argenx SE (ARGX) Stock Forecast, Price Target & Predictions

OverviewOwnershipChartTranscripts

ARGX Stock Forecast

argenx SE (ARGX) stock forecast, based on 35 Wall Street analysts, predicts a 12-month average price target of $1,014.20, with a high of $1,317.00 and a low of $818.00. This represents a 21.73% increase from the last price of $833.16.

$350 $550 $750 $950 $1 $1 High: $1317 Avg: $1014.2 Low: $818 Last Closed Price: $833.16

ARGX Stock Rating

argenx SE stock's rating consensus is Buy, based on 35 Wall Street analysts. The breakdown includes 1 Strong Buy (2.86%), 29 Buy (82.86%), 5 Hold (14.29%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 35 5 29 1 Strong Sell Sell Hold Buy Strong Buy

ARGX Price Target Upside V Benchmarks

TypeNameUpside
Stockargenx SE21.73%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts31523
Avg Price Target$1.17K$1.04K$966.00
Last Closing Price$833.16$833.16$833.16
Upside/Downside40.31%24.42%15.94%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 265152-123
Dec, 255161-123
Nov, 25616--123
Oct, 25616--123
Sep, 256161--23
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 20, 2026Wells Fargo$1.32K$800.0164.62%58.07%
Jan 08, 2026Danielle BrillTruist Financial$1.03K$822.9425.16%23.63%
Jan 08, 2026Sean LaamanMorgan Stanley$1.16K$822.9440.96%39.23%
Dec 18, 2025Yatin SunejaGuggenheim$1.16K$850.5736.38%39.23%
Dec 18, 2025Needham$1.01K$862.0516.70%20.75%
Dec 18, 2025Collen KusyRobert W. Baird$858.00$862.05-0.47%2.98%
Dec 17, 2025RBC Capital$925.00$863.377.14%11.02%
Dec 11, 2025Stifel Nicolaus$1.25K$889.7640.26%49.79%
Dec 09, 2025Xian DengUBS$910.00$900.761.03%9.22%
Dec 04, 2025Sean LaamanMorgan Stanley$1.11K$920.4520.59%33.23%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 20, 2026Wells FargoOverweightOverweighthold
Jan 12, 2026William BlairOutperformOutperformhold
Jan 08, 2026Morgan StanleyOverweightOverweighthold
Jan 08, 2026CitigroupBuyBuyhold
Jan 06, 2026BarclaysOverweightOverweighthold
Dec 17, 2025RBC CapitalOutperformOutperformhold
Dec 15, 2025JefferiesBuyBuyhold
Dec 15, 2025GuggenheimBuyBuyhold
Dec 15, 2025Bank of America SecuritiesBuyBuyhold
Dec 09, 2025UBSNeutralNeutralhold

Financial Forecast

EPS Forecast

$-20 $-7 $6 $19 $32 $45 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-7.99$-13.05$-5.16-----
Avg Forecast$-6.93$-13.84$-4.27$2.19$9.99$18.54$26.94$34.47
High Forecast$-6.13$-10.14$-3.65$3.24$17.75$35.69$34.50$42.05
Low Forecast$-8.38$-16.90$-6.65$0.91$3.87$7.41$13.79$24.60
Surprise %15.30%-5.71%20.84%-----

Revenue Forecast

$0 $2B $3B $5B $6B $8B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$497.28M$410.75M$1.23B-----
Avg Forecast$510.21M$441.26M$1.21B$2.17B$3.32B$4.40B$5.38B$6.49B
High Forecast$592.33M$516.41M$1.22B$2.20B$3.80B$4.52B$5.54B$7.58B
Low Forecast$464.78M$350.58M$1.18B$2.14B$2.82B$4.28B$5.21B$5.06B
Surprise %-2.54%-6.92%1.38%-----

Net Income Forecast

$-1B $-300M $400M $1B $2B $3B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-408.26M$-709.59M$-295.05M-----
Avg Forecast$-396.15M$-173.12M$-268.11M$118.49M$647.04M$1.30B$1.79B$1.97B
High Forecast$-350.29M$-54.70M$-84.72M$185.18M$1.01B$2.04B$1.97B$2.40B
Low Forecast$-479.04M$-291.53M$-451.51M$51.81M$221.00M$423.47M$788.32M$1.41B
Surprise %3.06%309.90%10.05%-----

ARGX Forecast FAQ

Is argenx SE stock a buy?

argenx SE stock has a consensus rating of Buy, based on 35 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 29 Buy, 5 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that argenx SE is a favorable investment for most analysts.

What is argenx SE's price target?

argenx SE's price target, set by 35 Wall Street analysts, averages $1.01K over the next 12 months. The price target range spans from $818 at the low end to $1.32K at the high end, suggesting a potential 21.73% change from the previous closing price of $833.16.

How does argenx SE stock forecast compare to its benchmarks?

argenx SE's stock forecast shows a 21.73% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for argenx SE over the past three months?

  • January 2026: 21.74% Strong Buy, 65.22% Buy, 8.70% Hold, 0% Sell, 4.35% Strong Sell.
  • December 2025: 21.74% Strong Buy, 69.57% Buy, 4.35% Hold, 0% Sell, 4.35% Strong Sell.
  • November 2025: 26.09% Strong Buy, 69.57% Buy, 0% Hold, 0% Sell, 4.35% Strong Sell.

What is argenx SE’s EPS forecast?

argenx SE's average annual EPS forecast for its fiscal year ending in December 2024 is $2.19, marking a -142.44% decrease from the reported $-5.16 in 2023. Estimates for the following years are $9.99 in 2025, $18.54 in 2026, $26.94 in 2027, and $34.47 in 2028.

What is argenx SE’s revenue forecast?

argenx SE's average annual revenue forecast for its fiscal year ending in December 2024 is $2.17B, reflecting a 76.93% increase from the reported $1.23B in 2023. The forecast for 2025 is $3.32B, followed by $4.4B for 2026, $5.38B for 2027, and $6.49B for 2028.

What is argenx SE’s net income forecast?

argenx SE's net income forecast for the fiscal year ending in December 2024 stands at $118.49M, representing a -140.16% decrease from the reported $-295M in 2023. Projections indicate $647.04M in 2025, $1.3B in 2026, $1.79B in 2027, and $1.97B in 2028.